| Altered miRNA expression in T regulatory cells in course of multiple sclerosis G De Santis, M Ferracin, A Biondani, L Caniatti, MR Tola, M Castellazzi, ... Journal of neuroimmunology 226 (1-2), 165-171, 2010 | 243 | 2010 |
| Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis E Fainardi, M Castellazzi, T Bellini, MC Manfrinato, E Baldi, I Casetta, ... Multiple Sclerosis Journal 12 (3), 294-301, 2006 | 173 | 2006 |
| Neurofilament ELISA validation A Petzold, A Altintas, L Andreoni, A Bartos, A Berthele, MA Blankenstein, ... Journal of immunological methods 352 (1-2), 23-31, 2010 | 109 | 2010 |
| Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing–remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI … E Fainardi, R Rizzo, L Melchiorri, L Vaghi, M Castellazzi, A Marzola, ... Journal of Neuroimmunology 142 (1-2), 149-158, 2003 | 102 | 2003 |
| 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis T Holmøy, SM Moen, TA Gundersen, MF Holick, E Fainardi, M Castellazzi, ... Multiple Sclerosis Journal 15 (11), 1280-1285, 2009 | 98 | 2009 |
| Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders C Contini, S Seraceni, R Cultrera, M Castellazzi, E Granieri, E Fainardi Interdisciplinary perspectives on infectious diseases 2010, 2010 | 96 | 2010 |
| Emerging topics and new perspectives on HLA-G E Fainardi, M Castellazzi, M Stignani, F Morandi, G Sana, R Gonzalez, ... Cellular and Molecular Life Sciences 68, 433-451, 2011 | 95 | 2011 |
| Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding R Rizzo, A Trentini, D Bortolotti, MC Manfrinato, A Rotola, M Castellazzi, ... Molecular and Cellular Biochemistry 381, 243-255, 2013 | 83 | 2013 |
| Autophagy and mitophagy biomarkers are reduced in sera of patients with Alzheimer’s disease and mild cognitive impairment M Castellazzi, S Patergnani, M Donadio, C Giorgi, M Bonora, C Bosi, ... Scientific reports 9 (1), 20009, 2019 | 80 | 2019 |
| Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study CE Leurs, HAM Twaalfhoven, BI Lissenberg-Witte, V Van Pesch, ... Multiple Sclerosis Journal 26 (8), 912-923, 2020 | 79 | 2020 |
| Role of HLA-G 14bp deletion/insertion and+ 3142C> G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis R Rizzo, D Bortolotti, NB Fredj, A Rotola, F Cura, M Castellazzi, ... Human immunology 73 (11), 1140-1146, 2012 | 74 | 2012 |
| Inhibition of multiple sclerosis–associated retrovirus as biomarker of interferon therapy G Mameli, C Serra, V Astone, M Castellazzi, L Poddighe, E Fainardi, ... Journal of neurovirology 14 (1), 73-77, 2008 | 69 | 2008 |
| Autophagy and mitophagy elements are increased in body fluids of multiple sclerosis-affected individuals S Patergnani, M Castellazzi, M Bonora, S Marchi, I Casetta, M Pugliatti, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (4), 439-441, 2018 | 64 | 2018 |
| Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis E Fainardi, R Rizzo, L Melchiorri, M Castellazzi, E Paolino, MR Tola, ... Multiple Sclerosis Journal 12 (1), 2-12, 2006 | 63 | 2006 |
| Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis E Caselli, M Boni, A Bracci, A Rotola, C Cermelli, M Castellazzi, D Di Luca, ... Journal of clinical microbiology 40 (11), 4131-4137, 2002 | 61 | 2002 |
| Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage M Castellazzi, C Tamborino, G De Santis, F Garofano, A Lupato, ... Brain Edema XIV, 137-140, 2010 | 60 | 2010 |
| Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis E Fainardi, M Castellazzi, S Seraceni, E Granieri, C Contini Current neurovascular research 5 (1), 60-70, 2008 | 60 | 2008 |
| Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases M Castellazzi, A Trentini, A Romani, G Valacchi, T Bellini, G Bonaccorsi, ... The International Journal of Biochemistry & Cell Biology 81, 356-363, 2016 | 56 | 2016 |
| Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with … C Contini, R Cultrera, S Seraceni, M Castellazzi, E Granieri, E Fainardi Multiple sclerosis journal 10 (4), 360-369, 2004 | 53 | 2004 |
| Multiple sclerosis and HERV-W/MSRV: a multicentric study G Arru, G Mameli, V Astone, C Serra, YM Huang, H Link, E Fainardi, ... International Journal of Biomedical Science: IJBS 3 (4), 292, 2007 | 52 | 2007 |
